Resources

  • Benefit-Risk SIG
  • Biomarkers SIG
  • Board of Directors
  • Bye-Laws
  • Committee Operating Guidelines
  • Conference
  • Council of Biopharmaceutical Statistics (CBS)
  • Epidemiology SIG
  • European Links (EFSPI)
  • External Affairs
  • Finance
  • HTA SIG
  • Introduction to Industry
  • Meta-Analysis Expert Group
  • Modelling and Simulation SIG
  • New Starters SIG
  • PSI Branding
  • Publications
  • Regulatory
  • RSS
  • Scientific
  • Template Documents
  • Toxicology SIG
  • Training

EventsFuture Events


  • PSI Webinar: Adaptive design: updated draft FDA guidance and its implications - Dates: 11 – 11 Jun, 2019

    In September 2018 the FDA published a guidance on adaptive design for clinical trials of drugs and biologics, updating (not finalizing) its initial draft from February 2010. The main focus of the webinar will be to provide an overview of its main contents, which will be presented by Jürgen Hummel (PPD). In addition, Kaspar Rufibach (Roche) will introduce an open-source statistical software for adaptive designs, RPACT (an R package that enables the design and analysis of confirmatory adaptive clinical trials). Kit Roes will also comment on the guidance from a European Regulatory perspective, which will be followed by a brief panel discussion.
  • Adaptive Designs - Dates: 24 – 24 Jun, 2019

    During this meeting we will hear about adaptive sample allocation for phase II/III designs, a new CONSORT extension reporting guideline for adaptive designs, regulatory aspects and case studies.
Pharm Research Associates

Principal Biostatistician

read more...

Autolus Therapeutics

Head of Statistical and Data Innovation as Head of Biometrics

read more...

Laegemiddelstyrelsen_UK_360x180_jobzonen-og-jobfinder

Leading Biostatistician with experience in Big Data and advanced analytics

read more...

Laegemiddelstyrelsen_UK_360x180_jobzonen-og-jobfinder

Biostatistician with experience in clinical drug development

read more...

bayerlogoresized

Statistician Opportunities in the UK

read more...